The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Nanda, Rita
PropertyValue
Person ID 1717
One or more keywords matched the following items that are connected to Nanda, Rita
Item TypeName
Concept Actins
Concept Aged, 80 and over
Concept Aged
Concept Complementary Therapies
Concept Biology
Concept Aneuploidy
Concept Antimetabolites, Antineoplastic
Concept Antineoplastic Combined Chemotherapy Protocols
Concept Analysis of Variance
Concept Antibodies, Monoclonal
Concept Benzamides
Concept Benzimidazoles
Concept Cell Count
Concept Cephalometry
Concept Bayes Theorem
Concept Bone Neoplasms
Concept Azacitidine
Concept Attitude to Health
Concept Biopsy
Concept Bridged-Ring Compounds
Concept California
Concept Colonic Neoplasms
Concept Combined Modality Therapy
Concept Imidazoles
Concept DNA Repair
Concept Chromosomes, Human, Pair 17
Concept Insulin-Like Growth Factor II
Concept Molar
Concept Esophagitis
Concept Insulin-Like Growth Factor I
Concept Personal Satisfaction
Concept Carcinoma, Hepatocellular
Concept Pharmacogenetics
Concept Immunohistochemistry
Concept Middle Aged
Concept Nigeria
Concept Phenylthiohydantoin
Concept Genetic Markers
Concept Receptors, Androgen
Concept Quinolines
Concept Cohort Studies
Concept Humans
Concept Incisor
Concept United States
Concept Biomarkers, Tumor
Concept Neprilysin
Concept Carcinoma, Adenosquamous
Concept Genes, BRCA2
Concept Up-Regulation
Concept Yoga
Concept DNA Modification Methylases
Concept Receptor, IGF Type 1
Concept Postmenopause
Concept Methylation
Concept Apoptosis
Concept Carcinoma, Lobular
Concept Carcinoma, Ductal, Breast
Concept Decision Support Systems, Clinical
Concept Angiogenesis Inhibitors
Concept BRCA1 Protein
Concept Immunoconjugates
Concept CpG Islands
Concept Antineoplastic Agents, Hormonal
Concept Insulin-Like Growth Factor Binding Protein 3
Concept Meditation
Concept Chemoradiotherapy, Adjuvant
Concept B7-H1 Antigen
Concept Genes, BRCA1
Concept BRCA2 Protein
Concept Promoter Regions, Genetic
Concept Quinazolines
Concept Senegal
Concept Electron Transport Complex I
Concept Meningeal Carcinomatosis
Concept Cathepsin K
Concept Chemoradiotherapy
Concept Triazoles
Concept Class I Phosphatidylinositol 3-Kinases
Concept Antibodies, Monoclonal, Humanized
Concept CTLA-4 Antigen
Concept Chemotherapy, Adjuvant
Concept Patient Satisfaction
Concept Receptor, ErbB-2
Concept Telemedicine
Concept DNA Methylation
Concept Neoadjuvant Therapy
Concept Genes, erbB-2
Concept Cyclin A
Concept Transcriptome
Concept Vascular Endothelial Growth Factor A
Concept Programmed Cell Death 1 Receptor
Concept Cell Line, Tumor
Concept Drug Discovery
Concept Cyclin A1
Concept Brain Neoplasms
Concept Camptothecin
Concept Communication
Concept Doxorubicin
Concept Follow-Up Studies
Concept Kinetics
Concept Longitudinal Studies
Concept Lymphocytes
Concept Prospective Studies
Concept Retrospective Studies
Concept T-Lymphocytes
Concept Conserved Sequence
Concept Genomics
Concept Estrogen Receptor alpha
Concept Proto-Oncogene Proteins c-akt
Concept Young Adult
Academic Article Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
Academic Article The molecular portraits of breast tumors are conserved across microarray platforms.
Academic Article BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.
Academic Article Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.
Academic Article Advances in breast cancer: pathways to personalized medicine.
Academic Article Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers.
Academic Article Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer.
Academic Article A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Academic Article Targeting the human epidermal growth factor receptor 2 (HER2) in the treatment of breast cancer: recent advances and future directions.
Academic Article Phase II trial of temsirolimus in patients with metastatic breast cancer.
Academic Article Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017.
Academic Article The role of tumor-associated macrophages in breast cancer progression (review).
Academic Article Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006.
Academic Article A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer.
Academic Article TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.
Academic Article TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer.
Academic Article Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019.
Academic Article The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer.
Academic Article Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003).
Academic Article Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: results of a secondary analysis of TBCRC 017.
Academic Article Adaptive Randomization of Neratinib in Early Breast Cancer.
Academic Article Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.
Academic Article TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis.
Academic Article Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.
Academic Article Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083.
Academic Article Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
Academic Article LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Academic Article Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.
Academic Article Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge", Napoli, November 30th 2016.
Academic Article Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
Academic Article Retrospective chart evaluation of hypercalcemia management in oncology patients at the University of Chicago Medical Center.
Academic Article Immune Checkpoint Blockade for Breast Cancer.
Academic Article Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers.
Academic Article Immune Checkpoint Inhibitor Therapy in Breast Cancer.
Academic Article First international TNBC conference meeting report.
Academic Article Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.
Academic Article TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer.
Academic Article MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial.
Academic Article Skeletal and dental changes associated with the treatment of deep bite malocclusion.
Academic Article Atezolizumab for the treatment of breast cancer.
Academic Article TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer.
Academic Article Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
Academic Article Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
Academic Article Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.
Academic Article Racial disparities in survival outcomes among breast cancer patients by molecular subtypes.
Academic Article TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.
Academic Article Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial.
Academic Article Novel therapies for triple-negative breast cancer.
Academic Article First-in-human evaluation of the novel mitochondrial complex I inhibitor ASP4132 for treatment of cancer.
Academic Article Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
Academic Article Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial.
Academic Article Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors.
Academic Article The impact of site-specific digital histology signatures on deep learning model accuracy and bias.
Academic Article Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update.
Academic Article Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.
Academic Article Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.
Academic Article Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.
Academic Article BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer.
Academic Article Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial.
Academic Article Differences Between Ipsilateral and Contralateral Early Parenchymal Enhancement Kinetics Predict Response of Breast Cancer to Neoadjuvant Therapy.
Academic Article Clinical trials of immunotherapy in triple-negative breast cancer.
Academic Article Highly accurate response prediction in high-risk early breast cancer patients using a biophysical simulation platform.
Academic Article Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.
Academic Article Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy.
Academic Article The evolving therapeutic landscape of antibody-drug conjugates in breast cancer.
Academic Article Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial.
Academic Article Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.
Concept Bevacizumab
Concept Trastuzumab
Concept Dasatinib
Concept Poly (ADP-Ribose) Polymerase-1
Concept Liquid Biopsy
Concept Circulating Tumor DNA
Concept Drug-Related Side Effects and Adverse Reactions
Concept Triple Negative Breast Neoplasms
Academic Article The Impact of Race and Age on Response to Neoadjuvant Therapy and Long-Term Outcomes in Black and White Women with Early-Stage Breast Cancer.
Academic Article Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy.
Academic Article Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence.
Academic Article A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer.
Academic Article Demographic and Clinical Characteristics Associated With Familiarity, Interest, and Use of Integrative Therapies Among Patients With Breast Cancer.
Academic Article Stress, Isolation, and Sleep Quality among Breast Cancer Survivors throughout the COVID-19 Pandemic: A Longitudinal Study in a Multi-Ethnic Cohort.
Academic Article Bilateral asymmetry of quantitative parenchymal kinetics at ultrafast DCE-MRI predict response to neoadjuvant chemotherapy in patients with HER2+ breast cancer.
Academic Article Racial/Ethnic Disparities in Telemedicine Utilization and Satisfaction Among Breast Cancer Patients During the COVID-19 Pandemic: A Mixed-Methods Analysis.
Academic Article Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
Academic Article Validation of the RSClin risk calculator in the National Cancer Data Base.
Academic Article Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
Academic Article Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.
Search Criteria
  • Genes erbB
  • 1